Sonova Reports Growth in 2023/24 with Strong Performance in Second Half

Sonova Holding AG announced a solid performance for the financial year 2023/24 with a reported increase in sales and earnings, particularly in the second half of the year. The group's sales in local currencies rose by 3.2%, reaching CHF 3,626.9 million. This growth was significantly supported by the Hearing Instruments and Cochlear Implants segments. Adjusted Group EBITA also saw an increase of 4.4% in local currencies. Despite this, exchange rate fluctuations posed challenges, leading to a 3.0% decrease in sales and a 8.2% decline in adjusted EBITA when reported in Swiss francs.

In response to these results, the Board of Directors plans to propose a dividend of CHF 4.30 per share at the upcoming Annual General Shareholders’ Meeting. Looking forward, Sonova is optimistic about the 2024/25 financial year, expecting a sales increase between 6% to 9% and an adjusted EBITA growth of 7% to 11% in local currencies.

CEO Arnd Kaldowski highlighted the effective execution of Sonova's strategy, which includes expanding engagement with consumers and advancing the product portfolio. Notable developments from the past year include enhancements to the Phonak Lumity platform and the launch of a battery-powered Audéo Lumity hearing aid.